Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives $19.00 Consensus Target Price from Analysts

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $19.00.

Several equities research analysts have recently weighed in on CCAP shares. Bank of America decreased their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. Wells Fargo & Company decreased their price objective on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Wednesday, August 14th. Finally, LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 price objective for the company.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. HighTower Advisors LLC raised its position in Crescent Capital BDC by 0.5% in the third quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock worth $2,624,000 after acquiring an additional 768 shares in the last quarter. Confluence Investment Management LLC raised its position in Crescent Capital BDC by 2.2% in the third quarter. Confluence Investment Management LLC now owns 73,206 shares of the company’s stock worth $1,354,000 after acquiring an additional 1,583 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Crescent Capital BDC in the second quarter worth $90,000. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Crescent Capital BDC by 14.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company’s stock valued at $1,517,000 after buying an additional 10,000 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in shares of Crescent Capital BDC in the second quarter valued at $195,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Price Performance

CCAP stock opened at $19.06 on Tuesday. The company has a market capitalization of $706.36 million, a P/E ratio of 7.47 and a beta of 0.81. Crescent Capital BDC has a twelve month low of $15.91 and a twelve month high of $19.63. The business has a 50 day simple moving average of $18.52 and a 200-day simple moving average of $18.47. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a dividend yield of 8.81%. The ex-dividend date is Tuesday, December 31st. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio is 65.88%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.